A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection (PATRON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01402908
Recruitment Status : Terminated (Due to Interim Analysis and business concerns)
First Posted : July 26, 2011
Last Update Posted : March 31, 2016
Information provided by (Responsible Party):
Medigen Biotechnology Corporation